{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:53:55Z","timestamp":1758970435889,"version":"3.41.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2002,11,1]],"date-time":"2002-11-01T00:00:00Z","timestamp":1036108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2002,11,1]],"date-time":"2002-11-01T00:00:00Z","timestamp":1036108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2002,11]]},"DOI":"10.1023\/a:1020571617274","type":"journal-article","created":{"date-parts":[[2003,3,18]],"date-time":"2003-03-18T20:12:43Z","timestamp":1048018363000},"page":"131-136","source":"Crossref","is-referenced-by-count":13,"title":["Effects of Anastrozole on Lipid Metabolism Compared with Tamoxifen in Rats"],"prefix":"10.1007","volume":"76","author":[{"given":"Yasuo","family":"Hozumi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoji","family":"Hakamata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Sasanuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeto","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"5094262_CR1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1210\/edrv-11-2-221","volume":"11","author":"RJ Santen","year":"1990","unstructured":"Santen RJ, Manni A, Harvey H, Redmond C: Endocrine treat-ment of breast cancer in women. Endocrine Rev 11: 221\u2013265, 1990","journal-title":"Endocrine Rev"},{"key":"5094262_CR2","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/(SICI)1097-0142(19970215)79:4<730::AID-CNCR10>3.0.CO;2-0","volume":"79","author":"AU Buzdar","year":"1997","unstructured":"Buzdar AU, Jones SE, Vogal CL, Wolter J, Plourde P, Webster A: A phase III trial comparing anastrozole (1 and 10 milligrams), a potent and selective aromatase inhibitor, with megestrol acetate in postmenopausal women with ad-vanced breast carcinoma. Arimidex Study Group. Cancer 79: 730\u2013739, 1997","journal-title":"Cancer"},{"key":"5094262_CR3","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/1040-8428(94)00172-3","volume":"21","author":"PE Lonning","year":"1995","unstructured":"Lonning PE, Lien E: Mechanisms of action of endocrine treat-ment in breast cancer. Crit Rev Oncol Haematol 21: 158\u2013193, 1995","journal-title":"Crit Rev Oncol Haematol"},{"key":"5094262_CR4","first-page":"129","volume":"3","author":"MJ Murphy","year":"1998","unstructured":"Murphy MJ: Molecular action and clinical relevance of aro-matase inhibitors. Oncology 3: 129\u2013130, 1998","journal-title":"Oncology"},{"key":"5094262_CR5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s002800100345","volume":"48","author":"R Murray","year":"2001","unstructured":"Murray R: Role of anti-aromatase agents in postmenopausal advanced breast cancer. Cancer Chemother Pharmacol 48: 259\u2013265, 2001","journal-title":"Cancer Chemother Pharmacol"},{"key":"5094262_CR6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0960-0760(95)00045-2","volume":"53","author":"PV Plourde","year":"1995","unstructured":"Plourde PV, Dyroff M, Dowsett M, Demers L, Yates R, Webster A: Arimidex: a new oral, once-a-day aromatase inhibitor. J Steroid Biochem Mol Biol 53: 175\u2013179, 1995","journal-title":"J Steroid Biochem Mol Biol"},{"key":"5094262_CR7","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/bjc.1996.531","volume":"74","author":"J Geisler","year":"1996","unstructured":"Geisler J, King N, Dowsett M, Ottestad I, Lundgren S, Walton P, Kormeset PO, Lonning PE: Influence of anastrozole (Arim-idex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatization and plasma oestrogen levels in postmenopausal women with breast cancer. Br J Cancer 74: 1286\u20131291, 1996","journal-title":"Br J Cancer"},{"key":"5094262_CR8","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1200\/JCO.2000.18.22.3758","volume":"18","author":"JM Nabholtz","year":"2000","unstructured":"Nabholtz JM, Buzdar A, Pollak M, Harwin W, Burton G, Mangallk A, Steinberg M, Webster A, von Euler M: Anas-trozole is superior to tamoxifen as first-line therapy for ad-vanced breast cancer in postmenopausal women: results of a North Americans multicenter randomized trial. Arimidex Study Group. J Clin Oncol 18: 3758\u20133767, 2000.","journal-title":"J Clin Oncol"},{"key":"5094262_CR9","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1200\/JCO.2000.18.22.3748","volume":"18","author":"J Bonneterre","year":"2000","unstructured":"Bonneterre J, Robertson JF, Thurlimann B, Krzakowski M, Maurlac L, Koralewski P, Vergote I, Webster A, Steinberg M, von Euler M: Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the Tamoxifen or Arimidex Random-ized Group Efficacy and Tolerability study. J Clin Oncol 18: 3748\u20133757, 2000","journal-title":"J Clin Oncol"},{"key":"5094262_CR10","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1002\/1097-0142(20011101)92:9<2247::AID-CNCR1570>3.0.CO;2-Y","volume":"92","author":"J Bonneterre","year":"2001","unstructured":"Bonneterre J, Buzdar A, Nabholtz JM, Robertson JF, Thurlimann B, von Euler M, Sahmoud T, Webster A, Steinberg M: Arimidex Writing Committee; Investigators Committee Members: Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast car-cinoma. Cancer 92: 2247\u20132258, 2001","journal-title":"Cancer"},{"key":"5094262_CR11","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1200\/JCO.2001.19.3.881","volume":"19","author":"PE Goss","year":"2001","unstructured":"Goss PE, Strasser K: Aromatase inhibitors in the treatment and prevention of breast cancer. J Clin Oncol 19: 881\u2013894, 2001","journal-title":"J Clin Oncol"},{"key":"5094262_CR12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0960-0760(01)00159-5","volume":"79","author":"J Ragaz","year":"2001","unstructured":"Ragaz J: Adjuvant trials of aromatase inhibitors: determining the future landscape of adjuvant endocrine therapy. J Steroid Biochem Mol Biol 79: 133\u2013141, 2001","journal-title":"J Steroid Biochem Mol Biol"},{"key":"5094262_CR13","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1200\/JCO.2002.20.3.751","volume":"20","author":"J Geisler","year":"2002","unstructured":"Geisler J, Haynes B, Anker G, Dowsett M, Lonning PE: Influ-ence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study. J Clin Oncol 20: 751\u2013757, 2002","journal-title":"J Clin Oncol"},{"key":"5094262_CR14","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","volume":"90","author":"B Fisher","year":"1998","unstructured":"Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N: National Surgical Adjuvant Breast and Bowel Project In-vestigators: Tamoxifen for prevention of breast cancer: Report of the national surgical adjuvant breast and bowel project P-1 study. J Natl Cancer Inst 90: 1371\u20131388, 1998","journal-title":"J Natl Cancer Inst"},{"key":"5094262_CR15","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nm0496-381","volume":"2","author":"DJ Grainger","year":"1996","unstructured":"Grainger DJ, Metcalfe JC: Tamoxifen: Teaching an old drug new tricks? Nature Med 2: 381\u2013385, 1996","journal-title":"Nature Med"},{"key":"5094262_CR16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0031-6997(24)01358-9","volume":"50","author":"JI MacGregor","year":"1998","unstructured":"MacGregor JI, Jordan VC: Basic guide to the mechanisms of antiestrogen action. Pharmacol Rev 50: 151\u2013196, 1998","journal-title":"Pharmacol Rev"},{"key":"5094262_CR17","first-page":"65","volume":"11","author":"PKJ Kinnunen","year":"1983","unstructured":"Kinnunen PKJ, Virtanen JA, Vaino P: Lipoprotein lipase and hepatic endothelial lipase: Their roles in plasma lipoprotein metabolism. Atheroscler Rev 11: 65\u2013105, 1983","journal-title":"Atheroscler Rev"},{"key":"5094262_CR18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3109\/10408369209114602","volume":"29","author":"J Auwerx","year":"1992","unstructured":"Auwerx J, Leroy P, Schoonjans K: Lipoprotein lipase: Recent contributions from molecular biology. Crit Rev Clin Lab Sci 29: 243\u2013268, 1992","journal-title":"Crit Rev Clin Lab Sci"},{"key":"5094262_CR19","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1507\/endocrj.44.745","volume":"44","author":"Y Hozumi","year":"1997","unstructured":"Hozumi Y, Kawano M, Miyata M: Severe hypertrigly-ceridemia caused by tamoxifen-treatment after breast cancer surgery. Endocrine J 44: 745\u2013749, 1997","journal-title":"Endocrine J"},{"key":"5094262_CR20","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1210\/jcem.83.5.4753","volume":"83","author":"Y Hozumi","year":"1998","unstructured":"Hozumi Y, Kawano M, Saito T, Miyata M: Effect of tamox-ifen on serum lipid metabolism. J Clin Endocrinol Metab 83: 1633\u20131635, 1998","journal-title":"J Clin Endocrinol Metab"},{"key":"5094262_CR21","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1002\/1097-0142(19860601)57:11<2123::AID-CNCR2820571106>3.0.CO;2-2","volume":"57","author":"LD Brun","year":"1986","unstructured":"Brun LD, Gagne C, Rousseau C, Moorjanis S, Lupien PJ: Severe lipemia induced by tamoxifen. Cancer 57: 2123\u20132126, 1986","journal-title":"Cancer"},{"key":"5094262_CR22","first-page":"36","volume":"53","author":"Y Hozumi","year":"2000","unstructured":"Hozumi Y, Kawano M, Hakamata Y, Miyata M, Jordan VC: Tamoxifen inhibits lipoprotein activity: in vivo and in vitro studies. Horm Res 53: 36\u201339, 2000","journal-title":"Horm Res"},{"key":"5094262_CR23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0022-2275(20)43094-9","volume":"10","author":"P Belfrage","year":"1969","unstructured":"Belfrage P, Vaughan M: Simple liquid\u2013liquid partition system for isolation of labeled oleic acid from mixtures of glycerides. J Lipid Res 10: 341\u2013344, 1969","journal-title":"J Lipid Res"},{"key":"5094262_CR24","doi-asserted-by":"crossref","first-page":"860","DOI":"10.7326\/0003-4819-115-11-860","volume":"115","author":"RR Love","year":"1991","unstructured":"Love RR, Wiebe DA, Newcomb PA, Cameron L, Leventhal H, Jordan VC: Effects of tamoxifen on cardiovascular risk factors in postmenopausal women. Ann Int Medicine 115: 860\u2013864, 1991","journal-title":"Ann Int Medicine"},{"key":"5094262_CR25","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/bmj.303.6800.435","volume":"303","author":"CC McDonald","year":"1991","unstructured":"McDonald CC, Stewart HJ: Fatal myocardial infarction in the Scottish Adjuvant Tamoxifen trial. BMJ 303: 435\u2013437, 1991","journal-title":"BMJ"},{"key":"5094262_CR26","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/jnci\/85.17.1398","volume":"85","author":"LE Rutqvist","year":"1993","unstructured":"Rutqvist LE, Mattsson A: Cardiac and thromboembolic mor-bidity among postmenopausal women with early-stage breast cancer in a randomized trial of adjuvant tamoxifen. J Natl Cancer Inst 85: 1398\u20131406, 1993","journal-title":"J Natl Cancer Inst"},{"key":"5094262_CR27","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1093\/jnci\/86.20.1534","volume":"86","author":"RR Love","year":"1994","unstructured":"Love RR, Wiebe DA, Feyzi JM, Newcomb PA: Effects of tamoxifen on cardiovascular risk factors in postmenopausal women after 5 years of treatment. J Natl Cancer Inst 86: 1534\u20131539, 1994","journal-title":"J Natl Cancer Inst"},{"key":"5094262_CR28","first-page":"3191","volume":"80","author":"AB Grey","year":"1995","unstructured":"Grey AB, Stapleton JP, Evans MC, Reid IR: The effect of the anti-estrogen tamoxifen on cardiovascular risk factors in normal postmenopausal women. J Clin Endocrinol Metab 80: 3191\u20133195, 1995","journal-title":"J Clin Endocrinol Metab"},{"key":"5094262_CR29","first-page":"625","volume":"4","author":"DP Mikhailidis","year":"1997","unstructured":"Mikhailidis DP, Ganotakis ES, Georgoulias VA, Vallance VT, Winder AF: Tamoxifen-induced hypertriglyceridemia: seven cases reports and suggestions for remedial action. Oncol Rep 4: 625\u2013628, 1997","journal-title":"Oncol Rep"},{"key":"5094262_CR30","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0936-6555(98)80019-8","volume":"10","author":"BM Colls","year":"1998","unstructured":"Colls BM, George PM: Severe hypertriglyceridaemia and hypercholesteroleamia associated with tamoxifen use. Clin Oncol (R Coll Radiol) 10: 270\u2013271, 1998","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"5094262_CR31","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/0002-8703(86)90296-6","volume":"112","author":"WP Castelli","year":"1986","unstructured":"Castelli WP: The triglyceride issue: a view from Framingham. Am Heart J 112: 432\u2013437, 1986","journal-title":"Am Heart J"},{"key":"5094262_CR32","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1161\/01.CIR.96.8.2520","volume":"96","author":"JM Gaziano","year":"1997","unstructured":"Gaziano JM, Hennekens CH, Odonnell CJ, Breslow JL, Buring JE: Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation 96: 2520\u20132525, 1997","journal-title":"Circulation"},{"key":"5094262_CR33","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0959-8049(01)00155-1","volume":"37","author":"MS Elisaf","year":"2001","unstructured":"Elisaf MS, Bairaktari Eth, Nicolaides C, Kakaidi B, Tzallas CS, Kastraki A, Pavlidis NA: Effects of letrozole on the lipid profile in postmenopausal women with breast cancer. Eur J Cancer 37: 1510\u20131513, 2001","journal-title":"Eur J Cancer"},{"key":"5094262_CR34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0002-9378(98)70634-9","volume":"178","author":"TM Price","year":"1998","unstructured":"Price TM, O'Brien SN, Welter BH, George R, Anandjiwala J, Kilgore M: Estrogen regulation of adipose tissue lipoprotein lipase \u2013 Possible mechanism of body fat distribution. Am J Obstet Gynecol 178: 101\u2013107, 1998","journal-title":"Am J Obstet Gynecol"},{"key":"5094262_CR35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00682745","volume":"30","author":"PV Ploude","year":"1994","unstructured":"Ploude PV, Dyroff M, Dukes M: Arimidex: a potent and selective fourth-generation aromatase inhibitor. Breast Cancer Res Treat 30: 103\u2013111, 1994","journal-title":"Breast Cancer Res Treat"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1020571617274.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1020571617274\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1023\/A:1020571617274","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1020571617274.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T04:05:26Z","timestamp":1750478726000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1020571617274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,11]]}},"alternative-id":["5094262"],"URL":"https:\/\/doi.org\/10.1023\/a:1020571617274","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[2002,11]]}}}